News

Hosted on MSN1mon
US FDA approves syringe version of Argenx's immune disorder drug
Argenx said the Vyvgart Hytrulo prefilled syringe will be available within the next two weeks and that it would have a comparable price to the subcutaneous vial. "The new version is going to make ...
Yahoo Finance29d
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
Vyvgart Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. The single-dose ...
Pharmabiz26d
Halozyme announces US FDA approval of argenx's Vyvgart Hytrulo prefilled syringe co-formulated with ENHANZE for self-injection for gMG and CIDP
Vyvgart Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. Patients are able to self ...
Medscape27d
FDA OKs Vyvgart Hytrulo Prefilled Syringe for Generalized Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy
The prefilled syringe will be available as a 20-to-30-second subcutaneous injection by a patient or caregiver after appropriate training or by a healthcare professional. The approval is supported ...
US FDA approves syringe version of Argenx's immune disorder drug
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster immune disorder drug, Vyvgart, giving patients a more convenient option of ...
Seeking Alpha1mon
Halozyme Announces FDA Approval of argenx's VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic ...
VYVGART ® Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. Patients are able ...